CONTRAFECT Corp (CFRXQ)
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Address
28 WELLS AVENUE
YONKERS, NY 10701
Founded
2008
Number of Employees
-
Website
http://www.contrafect.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)